Development and validation of a reverse-phase liquid chromatographic method for assay and related substances of abacavir sulfate

Journal of Separation Science

Volumn 30, Issue 1, 2007, Pages 28-34

  Seshachalam, U ^a   Haribabu, B ^a   Chandrasekhar, K B ^b  

^a Matrix Laboratories Limited   (India)

^b JNTUA COLLEGE OF ENGINEERING   (India)

Author keywords

Abacavir; Drug substance; Response factors; Stability indicating; System suitability

Indexed keywords

ABACAVIR; DRUG SUBSTANCE; ISOCRATIC LIQUID CHROMATOGRAPHIC METHOD; REVERSE-PHASE LIQUID CHROMATOGRAPHIC METHOD;

DRUG PRODUCTS; HYDROLYSIS; IMPURITIES; OXIDATION; PHOTOLYSIS; QUALITY CONTROL; STRESSES;

LIQUID CHROMATOGRAPHY;

4 (2 AMINO 6 CHLORO 9H PURINYL) 2 CYCLOPENTENE 1 METHANOL; 4 (2,6 DIAMINO 1H PURIN 9 YL)CYCLOPENT 2 ENEYLMETHANOL; 4 [(2,5 DIAMINO 6 CHLOROPYRIMIDINE 4 YLAMINO)CYCLOPENT 2 ENE 1 YL]METHANOL; ABACAVIR; METHANOL DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; DEGRADATION; DRUG DEGRADATION; DRUG DETERMINATION; DRUG IMPURITY; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; HYDROLYSIS; OXIDATION; PHOTOLYSIS; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

ANTI-HIV AGENTS; CHROMATOGRAPHY, LIQUID; DIDEOXYNUCLEOSIDES;

EID: 33846503232     PISSN: 16159306     EISSN: 16159314     Source Type: Journal    
DOI: 10.1002/jssc.200600209     Document Type: Article

References (12)

1. Stefania, N., Alessio, B., Giuseppe, L, Pasaqale, N., et al., J. Chromatogr. B 2006, 831, 258-266.
2. Elisabete, A. P., Gustavo, A. M., Marina, F. M. T., J, Chromatogr. A 2005, 1091, 169-176.
3. Verweji-van, C. P. W. G. M. W., Aarnoutse, R. E., Burger, D. M., J. Chromatogr. B 2005, 816, 121-129.
4. Naser, L. R., Richard, R. T., Kashuba, D. M., J. Chromatogr. B. 2003, 791, 137-147.
5. Joshua, R. R., Caroline, G. M., J. Chromatogr. B 2001, 762, 165-173.
6. Aymard, G., Legrand, M., Trichereau, N., Diquet, B., J. Chromatogr. B 2000, 744, 227-240.
7. Agnes, I. V., Rolf, W. S., Richard, M. W. H., Jos, H. B., J. Chromatogr. B 1999, 736, 123-128.
8. Yalcin, O., Ayhan, S., Sibel, A. C., J. Liq. Chromatogr. Relat. Technol. 2005, 28, 423-437.
9. Salut, M. F., Pilar, M., Cecilia, F. L., Eduardo, L. M., Biomed. Chromatogr. 2004, 18, 862-865.
10. Severine, C., Dimitri, S., Mikael, L., Alian, P., et al., J. Mass. Spectrom. 2005, 40, 9-18.
11. ICH International conference on harmonization of technical requirements for registration of Pharmaceuticals for Human use, Impurities in New Drug Substances, Geneva, Switzerland 2002, Q3A (R1).
12. ICH International conference on harmonization of technical requirements for registration of Pharmaceuticals for Human use, Impurities in New Drug Products, Geneva, Switzerland 2003, Q313 (R1).